Fidelis Care does cover Ozempic, but only for type 2 diabetes and only on certain plans. Medicaid Managed Care members get it through NYRx as a preferred GLP-1 agonist, and Wellcare by Fidelis Care Medicare members have it on their 2026 formulary. The Essential Plan and Ambetter from Fidelis Care formularies do not list Ozempic at all. Every approval requires prior authorization, and no Fidelis plan covers Ozempic for weight loss.
Coverage by Fidelis Plan
Fidelis offers several plan types, and the answer to the coverage question depends entirely on which one you have.1Fidelis Care. Shop for a Plan
If you have Fidelis Medicaid Managed Care, your pharmacy benefits run through NYRx, New York’s Medicaid fee-for-service pharmacy program.2Fidelis Care. Pharmacy Services On the NYRx Preferred Drug List revised June 2026, Ozempic is a preferred GLP-1 agonist for type 2 diabetes, listed alongside Trulicity, Victoza, and exenatide. Every drug in this class requires a clinical criteria review.3NYRx. NYRx Preferred Drug Quick List
If you have the Fidelis Essential Plan, Ozempic is not on the 2026 formulary. Unlisted drugs are non-formulary, so coverage requires a formulary exception.4Fidelis Care. Essential Plan 2026 Formulary
If you have Ambetter from Fidelis Care, a Qualified Health Plan on the New York marketplace, neither Ozempic nor semaglutide appears on the 2026 formulary. As with the Essential Plan, you would need to request an exception.5Fidelis Care. QHP 2026 Formulary
If you have Wellcare by Fidelis Care Medicare, Ozempic is on the 2026 formulary with both prior authorization and quantity limits. Other GLP-1s on that formulary, including Mounjaro, Rybelsus, and Trulicity, carry the same restrictions.6Fidelis Care. 2026 Alternative Covered Drugs, Wellcare by Fidelis Care
Prior Authorization and the Diabetes Requirement
Across every Fidelis plan, Ozempic requires prior authorization. The review confirms the prescription matches an FDA-approved use. For Ozempic, those uses are treatment of type 2 diabetes and reduction of cardiovascular death, non-fatal heart attack, or non-fatal stroke in patients with type 2 diabetes and established cardiovascular disease.7Fidelis Care. Appropriate Use of GLP-1 Agonists
Fidelis has told providers it may ask for additional documentation to verify what the prior authorization form claims. The insurer has flagged a high volume of requests that look like off-label use and has called prescribing Ozempic for obesity alone “inappropriate.”8Fidelis Care. Provider Resources The published Fidelis materials do not state whether step therapy is required, though they note that covered and preferred products vary by plan.7Fidelis Care. Appropriate Use of GLP-1 Agonists
Why Weight Loss Is Not Covered
No Fidelis plan covers Ozempic for weight loss. The insurer draws a firm line between Ozempic, which is FDA-approved for diabetes, and Wegovy, a different formulation of semaglutide approved for weight management.7Fidelis Care. Appropriate Use of GLP-1 Agonists A patient seeking weight-loss coverage needs a plan that covers obesity treatment and a prescription for an obesity-indicated drug, not Ozempic.
For Medicaid members, the exclusion is also a state rule. NYRx has stated that weight loss “is not and never has been a Medicaid-covered indication” and that GLP-1 agonists including Ozempic are “excluded from coverage for weight loss indications.”9NYRx. NYRx Executive Order Notification
If Your Ozempic Request Is Denied
Formulary Exceptions
Essential Plan and Ambetter members whose formularies do not list Ozempic can have their prescriber submit a Medication Request Form asking Fidelis to make an exception. The request has to include clinical documentation of medical necessity. Fidelis reviews these on criteria such as documented failure of preferred alternatives, allergic reactions to formulary drugs, or situations where a formulary drug is medically inappropriate.4Fidelis Care. Essential Plan 2026 Formulary Essential Plan pharmacy prior authorizations go in by fax to 844-235-4852 or electronically through CoverMyMeds or Surescripts.10Fidelis Care. Provider Resources, Essential Plan
Wellcare by Fidelis Care Medicare members submit formulary exceptions online through the Wellcare Medication Request Form, by fax, or by mail, with a prescriber’s medical justification.11Fidelis Care. Wellcare Medicare Prescription Drug Information
Internal Appeals
If coverage is denied outright, you can appeal. Medicare members have 60 to 65 days from the denial notice to submit a redetermination request, depending on the plan document. The appeal should include the prescriber’s statement explaining why the plan’s coverage criteria are not appropriate for you, the relevant medical records, and a copy of the denial. Expedited appeals, decided within 72 hours, are available when a standard seven-day wait could pose a serious health risk and a prescriber provides a supporting statement.12Fidelis Care. Redetermination of Medicare Prescription Drug Denial
External Appeals
Once the internal appeals process is exhausted, New York members can file an external appeal with the state Department of Financial Services within four months of the plan’s final denial. Appeals can be filed online, by email, fax, or certified mail. For non-formulary drug disputes, decisions are generally issued within 72 hours, or within 24 hours for expedited requests. Plans may charge up to $25 per appeal, capped at $75 per year. The fee is waived for Medicaid and Child Health Plus members and refunded if the appeal succeeds.13New York DFS. File an External Appeal
How Fidelis Appeals Have Been Decided
External appeal records give some sense of what reviewers accept. In a 2023 case involving Ozempic, a Fidelis denial was upheld for a teenage patient with obesity, pre-diabetes, and non-alcoholic fatty liver disease but no type 2 diabetes diagnosis. The independent reviewer found Ozempic was not medically necessary because the patient did not have the condition the drug is FDA-approved to treat, and noted that the appropriate obesity medication would be Wegovy.14New York DFS. External Appeal Case 202304-161253
A separate 2023 case shows the other side. A Fidelis Essential Plan denial of Wegovy was overturned after an independent reviewer determined the medication was medically necessary to prevent weight regain in a patient who had achieved significant weight loss from a baseline BMI of 54.15New York DFS. External Appeal Case 202303-160505 The two outcomes point the same direction: Ozempic coverage is tied to a confirmed type 2 diabetes diagnosis, and weight-related claims belong with Wegovy.
Confirm Your Own Coverage
Formularies and preferred drug lists change, and the one that matters is yours. Medicaid members can check the NYRx Preferred Drug List at newyork.fhsc.com or call the state Medicaid Helpline at 1-800-541-2831.16Fidelis Care. Member Pharmacy Members on other Fidelis plans can call Member Services at 1-888-343-3547 or pull their plan-specific formulary from the Fidelis Care website.2Fidelis Care. Pharmacy Services